Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00807586 · ClinicalTrials.gov registry record · Phase 4
Corticosteroid Pulse After Ablation
A Phase 4 study, sponsored by Minneapolis Heart Institute Foundation.
- Completed
- Registry status
- Phase 4
- Development phase
- 119
- Enrollment target
NCT00807586 is a Phase 4 study that has completed, run by Minneapolis Heart Institute Foundation. The registered enrollment target is 119 participants.
The verdict
NCT00807586, a Phase 4 study, has completed, sponsored by Minneapolis Heart Institute Foundation.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 119 participants
- Enrollment target
Study Summary
Radiofrequency ablation is an effective treatment for atrial fibrillation. However, about 20% of the time the atrial fibrillation recurs. Steroids given after the ablation may decrease inflammation caused by the ablation and thus improve healing and decrease the chance of recurrence of atrial fibrillation. In this study patients will be randomized to receive intravenous steroids or not immediately following the ablation.
Interventions
- DRUG Placebo
- DRUG Solumedrol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2008-12 |
| Est. Completion | 2013-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00807586
The ClinicalTrials.gov registry entry for NCT00807586 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Minneapolis Heart Institute Foundation, which has 22 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00807586 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00807586 about?
NCT00807586 is a clinical study titled "Corticosteroid Pulse After Ablation". Radiofrequency ablation is an effective treatment for atrial fibrillation. However, about 20% of the time the atrial fibrillation recurs. Steroids given after the ablation may decrease inflammation caused by the ablation and thus improve healing and decrease the chance of recurrence of atrial fibril...
What is the current status of trial NCT00807586?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 119 participants. The study started on 2008-12. Estimated completion is 2013-12.
What interventions are being tested in trial NCT00807586?
The interventions under investigation include: Placebo (DRUG), Solumedrol (DRUG).
Who is sponsoring clinical trial NCT00807586?
This trial is sponsored by Minneapolis Heart Institute Foundation, which has 22 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.